AAAAAA

   
Results: 1-13 |
Results: 13

Authors: CHANDRASEKAR PH MOMIN F KARANES C ABELLA S RATANATHARATHORN V SENSENBRENNER L
Citation: Ph. Chandrasekar et al., DISSEMINATED TOXOPLASMOSIS IN MARROW RECIPIENTS - A REPORT OF 3 CASESAND A REVIEW OF THE LITERATURE, Bone marrow transplantation, 19(7), 1997, pp. 685-689

Authors: VARTERASIAN M RATANATHARATHORN V UBERTI JP KARANES C ABELLA E MOMIN F KASTENSPORTES C ALKATIB A LUM L HEILBRUN LK SENSENBRENNER LL
Citation: M. Varterasian et al., CLINICAL COURSE AND OUTCOME OF PATIENTS WITH HODGKINS-DISEASE WHO PROGRESS AFTER AUTOLOGOUS TRANSPLANTATION, Leukemia & lymphoma, 20(1-2), 1995, pp. 59-65

Authors: SHEARER C CHANDRASEKAR PH SENSENBRENNER L RATANATHARATHORN V KARANES C MOMIN F ABELLA S LUM L UBERTI J
Citation: C. Shearer et al., PULMONARY NOCARDIOSIS IN A PATIENT WITH A BONE-MARROW TRANSPLANT, Bone marrow transplantation, 15(3), 1995, pp. 479-481

Authors: VARTERASIAN M RATANATHARATHORN V KARANES C UBERTI J MOMIN F ABELLA E LUM LG HEILBRUN LK SENSENBRENNER LL
Citation: M. Varterasian et al., BONE-MARROW TRANSPLANTATION FOR MULTIPLE-MYELOMA - THE WAYNE-STATE EXPERIENCE, Bone marrow transplantation, 15(2), 1995, pp. 328-329

Authors: SHIBUYA TY MOMIN F ABELLA E JACOBS JR KARANES C RATANATHARATHORN V SENSENBRENNER LL LUM LG
Citation: Ty. Shibuya et al., SINUS DISEASE IN THE BONE-MARROW TRANSPLANT POPULATION - INCIDENCE, RISK-FACTORS, AND COMPLICATIONS, Otolaryngology and head and neck surgery, 113(6), 1995, pp. 705-711

Authors: TURKERI LN LUM LG UBERTI JP ABELLA E MOMIN F KARANES C SENSENBRENNER LL HAAS GP
Citation: Ln. Turkeri et al., PREVENTION OF HEMORRHAGIC CYSTITIS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANT PREPARATIVE REGIMENS WITH CYCLOPHOSPHAMIDE AND BUSULFAN - ROLE OF CONTINUOUS BLADDER IRRIGATION, The Journal of urology, 153(3), 1995, pp. 637-640

Authors: MOMIN F CHANDRASEKAR PH
Citation: F. Momin et Ph. Chandrasekar, ANTIMICROBIAL PROPHYLAXIS IN BONE-MARROW TRANSPLANTATION, Annals of internal medicine, 123(3), 1995, pp. 205-215

Authors: LUM L BITONTI O JIN NR GALOFORO S WALKER A LUM C ABELLA E BABINGTON R KARANES C MOMIN F UBERTI J RATANATHARATHORN V SENSENBRENNER L
Citation: L. Lum et al., INTRAVENOUS GAMMA-GLOBULIN (IVIG) DOES NOT ALTER IMMUNE PARAMETERS INA RANDOMIZED TRIAL AFTER BONE-MARROW TRANSPLANTATION (BMT), Experimental hematology, 22(8), 1994, pp. 680-680

Authors: MOMIN F RATNATHARATHORN V UBERTI J ABELLA E KARANES C CASE P LUM L SENSENBRENNER L
Citation: F. Momin et al., COMPARISON OF OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)USING HLA IDENTICAL SIBLING, MATCHED UNRELATED, AND RELATED HLA MISMATCHED DONORS, Experimental hematology, 22(8), 1994, pp. 715-715

Authors: RATANATHARATHORN V UBERTI J KARANES C ABELLA E LUM LG MOMIN F CUMMINGS G SENSENBRENNER LL
Citation: V. Ratanatharathorn et al., PROSPECTIVE COMPARATIVE TRIAL OF AUTOLOGOUS VERSUS ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH NON-HODGKINS-LYMPHOMA, Blood, 84(4), 1994, pp. 1050-1055

Authors: RATANATHARATHORN V KARANES C MOMIN F UBERTI JP SENSENBRENNER LL ABELLA E LUM LG
Citation: V. Ratanatharathorn et al., PREPARATIVE REGIMES WITHOUT TOTAL-BODY IRRADIATION (TBI) IN THE RECIPIENTS OF UNRELATED DONOR MARROW, Blood, 84(10), 1994, pp. 10000342-10000342

Authors: KARANES C UBERTI JP RATANATHARATHORN V LUM L ABELLA E MOMIN F SENSENBRENNER L
Citation: C. Karanes et al., CYCLOPHOSPHAMIDE, VP-16, AND BCNU (CVB) FOR AUTOLOGOUS AND ALLOGENEICBONE-MARROW TRANSPLANTATION (BMT) IN NON-HODGKINS-LYMPHOMA (NHL), Blood, 82(10), 1993, pp. 10000144-10000144

Authors: UBERTI JP KARANES C RATANATHARATHORN V LUM L ABELLA E MOMIN F SENSENBRENNER L
Citation: Jp. Uberti et al., BUSULFAN-BASED PREPARATIVE REGIMENS FOR ACUTE MYELOID-LEUKEMIA IN ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) - THE ROLE OF HIGH-DOSE CYTOSINE-ARABINOSIDE (ARA-C) FOR HIGH-RISK PATIENTS, Blood, 82(10), 1993, pp. 10000643-10000643
Risultati: 1-13 |